isotretinoin
isotretinoin is listed in the FDA National Drug Code directory with 47 NDC codes, marketed under brand names including Absorica LD, Absorica, Amnesteem. Available dosage forms: capsule, capsule, liquid filled.
Drug details
- Generic Name
- isotretinoin
- Brand Names
- Absorica LD, Absorica, Amnesteem
- Application Number
- NDA211913
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- NDC Codes
- 47
- Dosage Forms
- CAPSULE, CAPSULE, LIQUID FILLED
- Routes
- ORAL
- Active Ingredients
- ISOTRETINOIN
Indications and Usage
1 INDICATIONS AND USAGE Isotretinoin Capsules is indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, Isotretinoin Capsules is reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. Limitations of Use : If a second course of Isotretinoin Capsules treatment is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of treatment [see Dosage and Administration (2.2)]. Isotretinoin Capsules is a retinoid indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, Isotretinoin Capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. (1) Limitations of Use : If a second course of Isotretinoin Capsules treatment is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of treatment. (1)